Dermata Therapeutics, Inc. - Common Stock (NQ:DRMA)

0.8600 -0.0500 (-5.49%)

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Dermata Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 10, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 22, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 22, 2024

It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 16, 2024

Via Benzinga

Dermata to Present at the Emerging Growth Conference on April 3, 2024

March 27, 2024

Via ACCESSWIRE

Dermata to Present at the Emerging Growth Conference on February 7, 2024

February 01, 2024

Via ACCESSWIRE

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

November 09, 2023

Via ACCESSWIRE

DRMA Stock Earnings: Dermata Therapeutics Reported Results for Q4 2023 ↗

March 21, 2024

Dermata Therapeutics just reported results for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 05, 2024

Via Benzinga

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

Dow Turns Lower; ISM Services PMI Falls In December ↗

January 05, 2024

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded down 0.19% to 37,369.52 while the NASDAQ rose 0.16% to 14,533.16. The S&P...

Via Benzinga

Topics Stocks

Why Is Aesthetic Skin Conditions-Focused Dermata Therapeutics Stock Trading Higher Today? ↗

January 05, 2024

Dermata Therapeutics Inc (NASDAQ: DRMA) stock was trading higher Friday after the company announced the issuance of a new patent in Japan for its

Via Benzinga

Topics Intellectual Property

Why Is Applied Therapeutics (APLT) Stock Down 30% Today? ↗

January 05, 2024

Applied Therapeutics stock is tumbling on Friday as investors react to lackluster results from a Phase 3 clinical trial of AT-001.

Via InvestorPlace

Why Is CISO Global (CISO) Stock Down 14% Today? ↗

January 05, 2024

CISO Global stock is falling on Friday as investors in the company react to a new delisting notice over the low trading price of the shares.

Via InvestorPlace

Why Is Dermata Therapeutics (DRMA) Stock Up 62% Today? ↗

January 05, 2024

Dermata Therapeutics stock is heading higher on Friday as investors of DRMA shares react to a new patent for DMT410 in Japan.

Via InvestorPlace

Topics Intellectual Property

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 05, 2024

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket ↗

January 05, 2024

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of...

Via Benzinga

Topics Intellectual Property

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 05, 2024

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 04, 2024

Via Benzinga

Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis

January 04, 2024

Via ACCESSWIRE

Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne

December 20, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 20, 2023

Via Benzinga

Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 16, 2023

Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 16, 2023

Via Benzinga

Crude Oil Down 4%; Walmart Shares Fall After Q3 Results ↗

November 16, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.40% to 34,850.49 while the NASDAQ fell 0.35% to 14,055.15. The...

Via Benzinga

Topics Stocks

Dermata to Begin Enrolling Patients in DMT310 Phase 3 Acne Clinical Program in December 2023 based on Agreement with FDA on the Phase 3 Protocols

November 16, 2023

Via ACCESSWIRE

Dermata Announces Exercise of Warrants for $2.26 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

November 16, 2023

Via ACCESSWIRE

Top 5 Health Care Stocks That May Fall Off A Cliff This Month ↗

November 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.